05-10-2021 | EASD 2021 | Conference coverage | News
Omnipod DASH benefits confirmed in real-world study
Children and adults with type 1 diabetes achieve significant reductions in glycated hemoglobin and hypoglycemic events during their first 90 days of using the Omnipod DASH insulin pump system, show real-world data.
28-09-2021 | EASD 2021 | Conference coverage | News
DKA presentation similar for type 1 and type 2 diabetes
Diabetic ketoacidosis is three times more common with type 1 diabetes than with type 2 diabetes, but episode presentation and severity are similar between the two groups, show data presented at the virtual 57th EASD Annual Meeting.